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Abstract 
Background: The 22q11.2 deletion is associated with psychiatric and behavioural disorders, 
intellectual disability and multiple physical abnormalities. Recent research also indicates 
impaired coordination skills may be part of the clinical phenotype. This study aimed to 
characterise sensorimotor control abilities in children with 22q11.2 Deletion Syndrome 
(22q11.2DS) and investigate their relationships with co-occurring IQ impairments and 
psychopathology.  
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Methods: 54 children with 22q11.2DS and 24 unaffected sibling controls, comparable in age 
and gender, underwent kinematic analysis of their hand movements, whilst performing a 
battery of three visuo-manual coordination tasks that measured their tracking, aiming and 
steering abilities. Additionally, standardised assessments of full-scale IQ (FSIQ), attention 
deficit hyperactivity disorder, indicative autism spectrum disorder (ASD) and anxiety disorder 
symptomatology were conducted. 
Results: Children with 22q11.2DS showed deficits on seven of eight kinematic descriptors of 
movement quality across the three coordination tasks, compared to controls. Within 22q11.2DS 
cases, the extent of impairment on only three kinematic descriptors was significantly related to 
FSIQ after correction for multiple testing. Moreover, only error whilst visuo-manually tracking 
was nominally associated with ADHD symptom counts. 
Conclusions: Impairments in sensorimotor control are seen on a range of visuo-manual tasks 
in children with 22q11.2DS but the extent of these impairments are largely unrelated to the 
severity of other psychopathological and intellectual impairments commonly found in children 
with 22q11.2DS. 
Keywords: 22q11.2 Deletion Syndrome, Movement difficulties, Coordination, ADHD, ASD, 
anxiety 
Background 
22q11.2 deletion syndrome (22q11.2DS) is a chromosomal microdeletion disorder 
caused by a hemizygous microdeletion on the long arm of chromosome 22. It affects 1 in 2,000-
4,000 live births, though the rate in low-risk pregnancies is as high as 1 in 992 (1). The deletion 
is associated with developmental delay and increased risk of physical abnormalities and mental 
disorders (2). Impaired motor skills are gaining recognition as a feature of 22q11.2DS too, after 
one of the largest studies to date to assess coordination skills in children with 22q11.2DS (3) 
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found they scored significantly lower than sibling controls on a parental-report screening 
questionnaire, with 81% surpassing the threshold score for suspected developmental 
coordination disorder (DCD), compared to 6% of controls. DCD is a neurodevelopmental 
disorder characterised by specific difficulties with learning and performing coordinated 
movements, not otherwise explained by co-occurring physical or neurological impairments (4). 
An increased risk of coordination skill deficits in children with 22q11.2DS is consistent with 
earlier evidence indicating they typically achieve gross-motor milestones later (5), have 
abnormal development in areas of the brain associated with sensorimotor control (6,7) and 
demonstrate highly variable profiles on motor skill assessment batteries (such as the Movement 
ABC-2), although without specific sub-domains emerging as being consistently affected (3,8).  
Mild to moderate intellectual difficulties are common in children with 22q11.2DS, and 
low IQ is associated with performance on motor assessments in 22q11.2DS (3,9). However, 
the degree to which IQ impairments account for poor performance remains unclear due to 
conflicting reports of significant motor impairments persisting in 22q11.2DS even in 
comparisons with IQ-matched controls (10,11). (Although children with 22q11.2DS out-
perform IQ-matched controls on some visuo-manual tasks (12)). Similarly, 22q11.2DS is a 
well-established risk factor for several other neurodevelopmental disorders (13) that have the 
potential to confound performance on motor skill assessments, e.g., ADHD and ASD (14). 
Thus, the extent to which coordination difficulties in children with 22q11.2DS are attributable 
primarily to other non-sensorimotor forms of co-occurring psychopathology remains unclear. 
Given the complex picture of co-occurring deficits in 22q11.2DS, more objective and 
specific assessments of fundamental sensorimotor processing abilities are needed to determine 
as precisely as possible the sensorimotor difficulties that are present in the syndrome. However, 
only one study to-date (reported across two papers (15,16) has used kinematic analysis 
techniques to describe movement quality in 21 children with 22q11.2DS. This revealed 
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comparatively greater temporal and spatial errors compared to IQ-matched controls on a 
rhythmic visuo-manual tracking task, with the 22q11.2DS group’s kinematics suggesting the 
use of a more developmentally immature ‘ballistic’ movement strategy. Consequently, claims 
that sensorimotor control processes are directly affected in 22q11.2DS could be further 
strengthened by determining whether differences are consistently observable in the kinematics 
of children with 22q11.2DS whilst performing basic coordination tasks, which have limited 
cognitive demands.  
The present study conducted a more extensive and detailed assessment of the 
underlying sensorimotor control abilities of children with 22q11.2DS and unaffected sibling 
controls than previously attempted; utilising a battery of computerised tasks that assessed 
several fundamental coordination behaviours (aiming, tracking and steering) whilst recording 
precise end-point kinematic response data. Data on global development were also obtained, 
enabling us to test whether children with 22q11.2DS exhibited consistent evidence of 
compromised sensorimotor control abilities; and the extent to which any such impairments 
were related to IQ level and/or the co-occurring psychiatric symptoms common within children 
with 22q11.2DS (17).  
Methods 
Participants and procedure 
Fifty-four participants with 22q11.2DS (mean age: 13.73 years, age range: 6.45-18.56 
years) and 24 unaffected siblings (mean: 12.99 years, range: 8.50-16.95 years) who were 
comparable in age and gender (see Table 1) were recruited via UK Medical Genetics clinics, 
word of mouth, and advertisements through 22q11.2DS charities, using recruitment protocols 
approved by the NHS Ethics and Research and Development committees. Informed consent 
was obtained prior to recruitment from carers of the children. Inclusion criteria were age of 6 
 5 
years or older (in order for psychiatric assessments to be valid) and confirmed presence of the 
22q11.2 deletion in the child with the deletion. Presence of the 22q11.2 deletion between either 
low copy repeat regions A and B or A and D was confirmed by medical genetics laboratories 
or by the Cardiff University MRC Centre for Neuropsychiatric Genetics and Genomics using 
microarray techniques. All participants completed a battery of sensorimotor tasks, along with 
a standardised assessment of IQ, and assessments of attention deficit hyperactivity disorder 
(ADHD), indicative autism spectrum disorder (ASD) and anxiety symptoms (see Assessments 
section for details). All assessments were completed either in the participants’ homes or at the 
laboratory at Cardiff University. 
Assessments 
Sensorimotor control  
Each participant completed the Clinical Kinematic Assessment Tool  (CKAT)(18), a 
standardised computerised battery comprising three sub-tests of visuo-manual sensorimotor 
control. All sub-tests required participants use a handheld stylus to interact with 2-D visual 
stimuli presented on a tablet computer. Outcome measures for each sub-test were as follows. 
Tracking required participants to keep their stylus as close as possible to the centre of 
a circular target (5mm diameter) as it moved in a sinusoidal figure-8 pattern, at three increasing 
speeds, for three min, under two conditions: one with a guide-path illustrating the target’s 
trajectory, another without this additional assistance (presented first). Performance was 
described by Tracking Error (TE): the straight-line distance in millimetres from the moving 
target’s centre-point to the tip of the stylus, sampled at a rate of 120 Hz for the task’s duration. 
For analysis, TE was summarised by the mean and standard deviation (termed Intra-Individual 
Variability (IIV) hereafter) of this time series of response.  
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Aiming required participants to respond as quickly and accurately as possible to fifty 
consecutively displayed 5mm diameter circular ‘targets’ appearing on-screen. Both 
preparatory and online components of response within each discrete aiming movement were 
captured, via measurements of: Reaction Time (RT) and Time to Peak Speed (TPS) in seconds, 
Peak speed (PS) in millimetres per second, and Normalised Jerk index (NJ), a measure of 
“smoothness” of the movement profile (19). Participant’s median responses on each of these 
outcomes were analysed.  
Steering assessed the ability to exert precise force control to produce complex multi-
component movements of the stylus under time-constraints. Participants were instructed to 
move their stylus along a 4mm wide path (comprising an angular combination of straight-line 
and curved trajectories) from an on-screen ‘start’ to ‘finish’ zone, whilst minimising deviation 
from the path and also trying to stay within a transparent ‘pacing’ box. The ‘pacing’ box 
highlighted a smaller portion of the overall path and moved along it at a fixed speed from the 
start to finish, taking 36 seconds to do so. Path accuracy (PA) was measured as the mean error 
in millimetres between stylus position and the centre of the idealised reference path at each 
sampled point (at 120 Hz). Completion Time (CT) was the time taken to reach the ‘finish’ 
zone. Median value across six trials for each of these outcomes was analysed.  
For supplementary details regarding CKAT battery tasks and their kinematic outcomes 
see establishing papers: Flatters et al.(18) and Culmer et al.(19). 
Psychometric and psychopathological assessment 
Full scale IQ (FSIQ) was obtained by administering the Wechsler Abbreviated Scale of 
Intelligence (four subtests) (WASI) (20). Parents completed the Social Communication 
Questionnaire (SCQ) (21), with responses summed into a continuous score (0-39) of 
symptomatology that is indicative of ASD. An individual was classed as having indicative 
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ASD if they scored 15 or more on the ASQ. Additionally, the research-diagnostic Child and 
Adolescent Psychiatric Assessment (CAPA) (22) interview was conducted with the primary 
caregiver to measure anxiety and attention deficit/hyperactivity disorder symptoms and assign 
a DSM-5 research diagnosis of these disorders. Symptoms were counted as present if an 
individual scored ≥2 on the relevant question. anxiety symptoms included any symptom of 
generalised anxiety disorder, social phobia, specific phobia, separation anxiety, panic disorder 
with and without agoraphobia, agoraphobia and obsessive-compulsive disorder.  
Statistical analysis 
Before statistical analysis, all raw scores for kinematic (i.e. CKAT) outcome variables 
except Peak Speed (PS) and Completion Time (CT), were reciprocally transformed to resolve 
outliers and normalise the distributions. Statistical analysis was carried out in R-3.5.1 (23), on 
OSX-10.14.2. 
Analysis 1 investigated differences in sensorimotor control between groups (effect of 
Deletion Status) for each kinematic outcome variable after specifying age and gender as 
covariates, due to their well-established effects on sensorimotor performance (24). We did not 
include FSIQ as a covariate in these analyses as it is strongly correlated with deletion carrier 
status. For outcomes relating to Tracking, these ANCOVAs also examined whether Deletion 
Status interacted with other manipulations of task difficulty (i.e. variations in target-speed and 
presence of a guide-path). Analysis 2 used hierarchical linear regressions to investigate, within 
the children with 22q11.2DS specifically, the contribution of FSIQ to explaining performance 
on those kinematic outcomes where an effect of deletion status had been found in Analysis 1. 
These models controlled for age and gender at step one, then added FSIQ at a second step. 
Analysis 3 utilised equivalent hierarchical models, this time investigating at the second step 
the relationship between kinematic outcomes and symptom counts for ADHD, ASD and 
anxiety disorders in the 22q11.2DS group.  
 8 
A Bonferroni-Holm correction was used to correct p values for the number of 
comparisons made, and adjusted p values are reported alongside original p values in the text 
and tables. 
Results 
See Table 1 for summary demographic information. One child with 22q11.2DS was 
receiving Aripiprazole for psychosis and two children with 22q11.2DS were receiving 
methylphenidate. No other relevant medication use was noted. Indicative ASD symptoms were 
not available for one child with 22q11.2DS and one unaffected sibling control. One child with 
22q11.2DS had the smaller (1.5Mb) A-B deletion, while the remaining children had the typical 
(3Mb) A-D deletion.  
Table 1. Demographic information and summary statistics for age, IQ and psychopathology 
symptoms.   
  22q11.2DS Controls     
  n Mean (Range) sd n 
Mean 
(Range) sd t p 
Age 54 13.73 (6.45-18.6) 3.44 24 
12.99 (8.50-
16.95) 2.52 1.06 .292 
FSIQ 54 72.06 (51-105) 13.13 24 
108.25 (63-
139) 18.16 -8.79 <.001 
  n Median IQR n Median IQR W p 
ADHD Symptoms 54 3 7.75 24 0 0.00 1761 <.001 
Indicative ASD Symptoms 53 9 9.00 23 1 3.00 2545 <.001 
anxiety Symptoms 54 1 6.00 24 0 2.00 1198 .039 
Mother’s Ethnic Background n (families) %       
Caucasian  54 93.1       
Other 4 6.9       
Mother's Education Level n %       
High (University Degree and/or 
other postgraduate qualification) 12 20.7       
Low (O-Levels, GCSE’s) 10 17.2       
Middle (A- Level’s, Highers, 
vocational training) 29 50.0       
No school leaving exams 4 6.9       
Unknown 3 5.2       
Approximate Family Income n (families) %       
<=£19,999 8 13.8       
£20,000 - £39,999 14 24.1       
£40,000 - £59,999 16 27.6       
£60,000 + 14 24.1       
Unknown 6 10.3       
Note: 148 families took part, four families provided only a sibling control 
FSIQ: Full Scale IQ, ADHD: attention deficit hyperactivity disorder, ASD: autism spectrum disorder, 22q11.2DS: 
22q11.2 deletion syndrome 
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Analysis 1: Sensorimotor control in 22q11.2DS and sibling controls 
Tracking 
ANCOVA results indicated that visuo-manual tracking performance, in terms of both 
its average and intra-individual variability (i.e. mean Tracking Error and Standard Deviation 
of Tracking Error), was poorer in children with 22q11.2DS compared to siblings, with small 
to moderate effect sizes (see Table 2 and Figure 1 A.). Interaction terms within these models 
also indicated a significant interaction between Deletion Status and target speed for both Mean 
(F=6.80, df=2, p=.001, ηp2=.029) and Standard Deviation (F=7.08, df=1, p=.001, ηp2=.030) of 
Tracking Error. All other interactions between Deletion Status and experiment manipulations 
on this sub-test were not significant (p>.0056). These interactions arose due to the deficits in 
the performance between carriers and siblings reducing as target speed increased. This is 
demonstrated in Figure 1 B.  
Aiming 
ANCOVA results also illustrated that 22q11.2 deletion carriers’ aiming movements 
comprised a longer preparatory phase (longer Reaction Times) and, once initiated, exhibited 
increased Normalised Jerk and Time to Peak Speed compared to controls, with medium-to-
large effect sizes (Table 2). Deletion carriers had a lower Peak Speed compared to controls, 
with a medium effect size. 
Steering 
ANCOVAs of steering performance revealed no difference between deletion carriers 
and siblings for Completion Time but there were significant moderately-sized differences in 
Path Accuracy, with children with the deletion, on average, further away from the ideal path 
(Table 2).  
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Table 2. Mean performance on kinematic outcomes for children with 22q11.2 deletion 
(n=54) and controls (n=24).  
    22q11.2DS Controls     
Task Outcome Mean SD Mean SD df F p padj ηp2 
Tracking 
Mean Error 0.089 0.056 0.106 0.067 1 40.812 <.001 <.001 .082 
IIV of 
Error 0.147 0.094 0.185 0.105 1 46.617 <.001 <.001 .093 
Aiming 
Peak Speed 324.286 75.247 379.144 106.222 1 7.756 .007 .028 0.095 
Time to 
Peak Speed 1.7 0.267 1.845 0.296 1 10.482 .002 .012 .124 
Normalized 
Jerk 0.004 0.001 0.005 0.002 1 27.655 <.001 <.001 .272 
Reaction 
Time 2.848 0.442 3.03 0.477 1 9.846 .002 .013 .117 
Steering 
Path 
Accuracy 0.76 0.203 0.916 0.196 1 19.132 <.001 <.001 .205 
Completion 
Time 36.057 6.357 36.317 4.396 1 0.152 .698 .770 .002 
F values and statistics indicate main effect of deletion status for the models reported in the Analysis 1 sub-
section of this paper. 
Padj indicates p value after Bonferroni-holm adjustment 
Effect size thresholds: ηp2>.01 Small, >.09 Medium, >.25 Large (27) 
22q11.2DS: 22q11.2 Deletion Syndrome; IIV = Intra Individual Variability 
 
Analysis 2: Sensorimotor control and IQ in children with 22q11.2DS 
Hierarchical regression models were constructed for each of the six kinematic outcome 
measures where a significant effect of deletion status was found in Analysis 1. These outcomes 
were first regressed on age and gender, before the addition of FSIQ. For mean Tracking Error 
and its Intra-Individual Variability average performance across both conditions at the slowest 
target speed was analysed, due to the interactions with speed observed in Analysis 1.  
These models showed that addition of FSIQ increased predictive power for mean 
Tracking Error (R2 change=.09, F=7.15, df=1, p=.010, padj=.040), Time to Peak Speed (R2 
change=0.10, F=8.43, df=1, p=.005, padj=.025) and Path Accuracy (R2 change=0.12, F=10.69, 
df=1, p=.002 padj=.012), after corrections for multiple comparisons were applied. Before 
correction, nominal associations between FSIQ and Intra-Individual Variability of Tracking 
Error (R2 change=.09, F=6.00, df=1, p=.018, padj=.064) and Peak Speed (R2 change=.10, 
F=5.29, df=1, p=.026, padj=.077) were observed. No other relationships were found. Full 
results of these regression analyses are presented in Supplementary Table 1. 
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Analysis 3: Sensorimotor control and co-occurring psychopathology with 22q11.2DS 
Hierarchical models of each kinematic outcome regressed on the number of ADHD, 
indicative ASD or anxiety symptoms observed, after controlling for age and gender, revealed 
nominal (p<.05) associations between increased ADHD symptoms (R2 change=.07, F=5.31, 
df=1, p=.025, padj=.077) and increased mean Tracking Error. All other relationships were non-
significant before and after correction for multiple comparisons. Full results of these regression 
analyses are presented in Supplementary Table 2.  
Sensitivity analyses, excluding the three individuals receiving medication or the one 
carrying the 1.5 deletion from analyses 2 and 3 identified an additional nominal (p<.05) 
association between anxiety symptoms and Path Accuracy in children carrying the 22q11.2 
deletion (R2 change=.06, F=4.66, df=1, p=.036, padj=.093). All other results remained the 
same. 
 
Discussion 
The current study presents the most extensive and detailed investigation of 
sensorimotor control abilities in children with 22q11.2DS to date, in a sample more than twice 
the size of the only previous study to use objective kinematic analysis techniques (15,16). 
Movement kinematics for tracking, aiming and steering all indicated significant differences in 
these basic sensorimotor control behaviours in children with 22q11.2DS compared to their 
siblings.  
Rhythmic visuo-manual tracking deficits were expected given earlier work (16), but 
these deficits have been explored in more detail, allowing group differences in average 
accuracy and intra-individual variability to be established. Deficits in intra-individual 
variability were of equal, if not greater, size to between group differences in average accuracy. 
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This finding is interesting given increasing intra-individual variability is a noted cognitive 
symptom of several degenerative movement disorders (25,26), along with ADHD (27) and 
might indicate difficulties in maintaining stable performance levels within tasks (28,29). 
Related deficits in accuracy (but not speed) whilst steering, and smoothness of movement 
whilst aiming, also suggest that sensorimotor deficits in children with 22q11.2DS reflect 
specific problems with integrating feedback in a timely manner in order to make fluent online 
corrections. Abnormal jerk profiles have also been shown repeatedly to arise in individuals 
with degenerative movement disorders such as Parkinson’s disease (30,31). Such kinematic 
discrepancies are also consistent with other research finding coordination deficits relative to 
controls in children with 22q11.2DS lessen on tasks where time to respond is unconstrained 
(12). These patterns of results may suggest that there is a disruption in the ability to build and 
refine internal models for guiding and supervising action. 
The small number of significant relationships between kinematic variables and FSIQ 
and the limited variance in sensorimotor ability they explain (10-12% when significant) 
suggests that co-occurring IQ deficits are not the sole contributor to coordination difficulties 
in 22q11.2DS. Only accuracy when steering, time to peak speed when performing aimed 
movements and error when tracking an object were found to be related to FSIQ. If IQ 
impairment was causative of sensorimotor deficits in 22q11.2DS, we would expect severity of 
sensorimotor deficits to increase with the level of IQ impairment across many measures. the 
evidence presented here would suggest that in this population, where mild or moderate 
intellectual difficulties are common, motor difficulties are at most weakly associated with IQ 
level.  
Lastly, we found only nominal relationships between ADHD symptoms and average 
Tracking Error. The absence of consistent significant relationships between sensorimotor 
performance on the one hand and psychopathology or IQ on the other suggests that 
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sensorimotor impairment is not a consequence of generally poorer functional or coping levels 
but a specific component of the phenotype of 22q11.2DS. This result differs from previous 
research, where psychopathology symptoms were found to be strongly related to overall 
coordination (3), however, this earlier study relied on parental report, whilst the current study 
used objective and direct methods to assess sensorimotor control. In addition, the questionnaire 
used in the previous study, the developmental coordination disorder questionnaire (DCDQ) 
probes about more general aspects of movement including problems that affect daily life, such 
as writing or ball skills. Some of these aspects might be more likely to be affected by 
psychopathology, such as being nervous about feeling clumsy. Therefore, while it is reasonable 
to suspect that sensorimotor problems may underlie poor scores on the DCDQ, it is also likely 
that they would not explain the full scope of scores. Resolving this difference is important for 
the clinical evaluation of motor problems in 22q11.2DS. 
It should be noted that 22q11.2DS is a complex disorder, with many associated physical 
health conditions (2), and unfortunately, it was not possible to assess all neurological and/or 
musculoskeletal problems that might contribute to the sensorimotor deficits demonstrated here. 
However, in light of the present findings and the increasing evidence for movement disorders 
in 22q11.2DS across the lifespan (32), we suggest it is appropriate that formal motor 
assessments are added to the research and clinical standards for 22q11.2DS. This should 
facilitate earlier detection of movement disorders and implementation of appropriate help. This 
is important as movement difficulties in childhood have been shown to be related to greater 
problems in adulthood in non-genotyped populations (33,34). However, it is currently not 
known how early difficulties with motor skills can be identified in this population. The 
difficulty in reliably identifying coordination impairments in very young children (under 5-
years old) is even commented on in the most recent clinical recommendations for diagnosing 
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DCD (4). Indeed, which assessments would be the most sensitive and useful for this population 
are important research questions that should be addressed in the future. 
Conclusions 
In the present study, we have demonstrated a series of atypical sensorimotor control 
behaviours in children with 22q11.2DS that provide a plausible explanation for the deficits in 
coordination that have been noted in the syndrome. In addition, we highlight the relative 
independence of sensorimotor deficits from co-occurring IQ deficits and other potential 
associations with specific domains of psychopathology. This work further demonstrates the 
importance of sensorimotor difficulties in children with 22q11.2DS and strongly suggests that 
neurodevelopmental disorders of movement should be considered part of the clinical 
phenotype in 22q11.2DS. 
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Figure Legends: 
Figure 1. A) Boxplots of reciprocal mean tracking error (TE) and reciprocal Intra-Individual 
Variability of tracking error, by group and speed. B) Reciprocal mean tracking error (mean 
TE) and Intra-Individual Variability of TE (IIV of TE) by group and speed. Notes: Error bars 
indicate standard error of the mean; reciprocal transforms mean larger quantities in these 
graphs denote less error.  
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Supplementary Table 1. Hierarchical regression results for analysis 2, where sensorimotor 
outcome measures are predicted by Full scale IQ, with age and sex as covariates. 
Mean TE Model 1 Model 2 
  B SE Std.B p B SE Std.B p 
Constant 0.053 0.026  0.0446 -0.039 0.042  0.359 
Age 0.007 0.0017 0.51 0.000124 0.0078 0.0016 0.57 1.31e-05 
Sex -0.005 0.012 -0.052 0.67 -0.0032 0.011 -0.034 0.773 
FSIQ     0.0011 0.00041 0.31 0.0101 
R2 0.27    0.36    
 R2 Change F p adj.p     
 0.091 7.2 0.010 0.040         
IIV of TE Model 1 Model 2 
  B SE Std.B p B SE Std.B p 
Constant 0.044 0.056  0.44 -0.14 0.093  0.132 
Age 0.013 0.0036 0.44 0.00109 0.014 0.0035 0.5 0.000187 
Sex -0.0055 0.025 -0.028 0.827 -0.0019 0.024 -0.0098 0.936 
FSIQ     0.0022 0.00091 0.3 0.0178 
R2 0.2    0.29    
 R2 Change F p adj.p     
 0.085 6 0.018 0.064         
NJ Model 1 Model 2 
  B SE Std.B p B SE Std.B p 
Constant 0.00027 0.00054  0.617 -0.001 0.00091  0.274 
Age 0.00028 3.5e-05 0.75 1.94e-10 0.00029 3.5e-05 0.78 6.85e-11 
Sex -8.7e-05 0.00024 -0.034 0.719 -6.2e-05 0.00024 -0.024 0.794 
FSIQ     1.5e-05 9e-06 0.16 0.092 
R2 0.57    0.59    
 R2 Change F p adj.p     
 0.024 3 0.092 0.221         
PS Model 1 Model 2 
  B SE Std.B p B SE Std.B p 
Constant 310 48  3.51e-08 160 80  0.0487 
Age 0.62 3.1 0.028 0.845 2 3.1 0.091 0.52 
Sex 6.1 21 0.04 0.779 9 21 0.06 0.667 
FSIQ     1.8 0.78 0.32 0.0256 
R2 0.0019    0.097    
 R2 Change F p adj.p     
 0.096 5.3 0.026 0.077         
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TPS Model 1 Model 2 
  B SE Std.B p B SE Std.B p 
Constant 1 0.14  1.43e-09 0.5 0.23  0.0339 
Age 0.044 0.0092 0.57 1.45e-05 0.049 0.0088 0.63 9.11e-07 
Sex 0.087 0.063 0.16 0.175 0.097 0.059 0.18 0.106 
FSIQ     0.0065 0.0022 0.32 0.00549 
R2 0.31    0.41    
 R2 Change F p adj.p     
 0.099 8.4 0.005 0.025         
RT Model 1 Model 2 
  B SE Std.B p B SE Std.B p 
Constant 1.5 0.21  1.45e-09 0.96 0.35  0.00805 
Age 0.09 0.013 0.7 1.56e-08 0.095 0.013 0.74 3.52e-09 
Sex 0.17 0.092 0.2 0.0665 0.18 0.09 0.21 0.0462 
FSIQ     0.0067 0.0034 0.2 0.0544 
R2 0.47    0.51    
 R2 Change F p adj.p     
 0.038 3.9 0.054 0.142         
PA Model 1 Model 2 
  B SE Std.B p B SE Std.B p 
Constant 0.35 0.11  0.0018 -0.1 0.17  0.555 
Age 0.032 0.0069 0.54 2.97e-05 0.036 0.0065 0.61 1.12e-06 
Sex -0.048 0.047 -0.12 0.315 -0.039 0.044 -0.097 0.37 
FSIQ     0.0054 0.0017 0.35 0.00196 
R2 0.33    0.45    
 R2 Change F p adj.p     
  0.12 11 0.002 0.012         
TE: Tracking Error, IIV of TE: Intra-Individual Variability of Tracking Error, NJ: Normalised 
Jerk, TPS: Time to Peak Speed, RT: Reaction Time, PA: Path Accuracy 
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Supplementary Table 2. Hierarchical regression results for analysis 3, where sensorimotor 
outcome measures were predicted by ADHD symptoms, indicative ASD symptoms and anxiety 
symptoms, with age and gender as covariates 
Mean TE   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.053 0.026   0.0446 0.084 0.028   0.00441 
Age 0.007 0.0017 0.51 0.000124 0.0055 0.0017 0.4 0.00277 
Sex -0.005 0.012 -0.052 0.67 -0.0014 0.011 -0.015 0.901 
ADHD Count     -0.0029 0.0013 -0.29 0.0254 
R2 0.27    0.34    
 
R2 
Change F p adj. p     
 0.07 5.3 0.025 0.077     
IIV of TE   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.044 0.056   0.44 0.093 0.063   0.142 
Age 0.013 0.0036 0.44 0.00109 0.01 0.0039 0.36 0.0111 
Sex -0.0055 0.025 -0.028 0.827 0.00024 0.025 0.0012 0.992 
ADHD Count     -0.0047 0.0028 -0.23 0.1 
R2 0.2    0.24    
 
R2 
Change F p adj. p     
 0.042 2.8 0.100 0.226     
NJ   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.00027 0.00054   0.617 0.00044 0.00062   0.482 
Age 0.00028 3.5e-05 0.75 1.94e-10 0.00027 3.8e-05 0.72 4.47e-09 
Sex -8.7e-05 0.00024 -0.034 0.719 -6.8e-05 0.00024 -0.027 0.782 
ADHD Count     -1.6e-05 2.8e-05 -0.058 0.576 
R2 0.57    0.57    
 
R2 
Change F p adj. p     
 0.0027 0.32 0.576 0.740     
PS   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 310 48   3.51e-08 310 55   1.06e-06 
Age 0.62 3.1 0.028 0.845 0.87 3.4 0.04 0.799 
Sex 6.1 21 0.04 0.779 5.5 22 0.036 0.804 
ADHD Count     0.5 2.5 0.031 0.842 
R2 0.0019    0.0027    
 
R2 
Change F p adj. p     
 8e-04 0.04 0.842 0.866     
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TPS   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 1 0.14   1.43e-09 1 0.16   1.06e-07 
Age 0.044 0.0092 0.57 1.45e-05 0.046 0.01 0.59 2.98e-05 
Sex 0.087 0.063 0.16 0.175 0.083 0.064 0.16 0.204 
ADHD Count     0.0035 0.0073 0.062 0.633 
R2 0.31    0.32    
 
R2 
Change F p      
 0.0032 0.23 0.633 0.760     
RT   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 1.5 0.21   1.45e-09 1.5 0.24   4.35e-08 
Age 0.09 0.013 0.7 1.56e-08 0.09 0.015 0.7 1.37e-07 
Sex 0.17 0.092 0.2 0.0665 0.17 0.094 0.2 0.0702 
ADHD Count     -0.00082 0.011 -0.0087 0.939 
R2 0.47    0.47    
 
R2 
Change F p adj. p     
 6.2e-05 0.0059 0.939 0.939     
PA   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.35 0.11   0.0018 0.37 0.12   0.00362 
Age 0.032 0.0069 0.54 2.97e-05 0.031 0.0075 0.52 0.000165 
Sex -0.048 0.047 -0.12 0.315 -0.046 0.048 -0.11 0.35 
ADHD Count     -0.0021 0.0055 -0.048 0.706 
R2 0.33    0.33    
 
R2 
Change F p adj. p     
 0.0019 0.14 0.706 0.771     
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Mean TE   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.045 0.026   0.0931 0.054 0.029   0.0647 
Age 0.0074 0.0017 0.54 6.17e-05 0.0072 0.0017 0.52 0.000111 
Sex -0.0019 0.012 -0.02 0.873 -0.00014 0.012 -0.0015 0.991 
Ind. ASD     -0.00068 0.00083 -0.1 0.419 
R2 0.29    0.3    
 
R2 
Change F p adj. p     
 0.0095 0.67 0.419 0.628     
IIV of TE    Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.025 0.057   0.66 0.049 0.062   0.437 
Age 0.014 0.0037 0.47 0.000544 0.013 0.0037 0.46 0.000937 
Sex 0.0014 0.025 0.0071 0.956 0.0057 0.026 0.029 0.823 
Ind. ASD     -0.0017 0.0018 -0.12 0.347 
R2 0.22    0.24    
 
R2 
Change F p adj. p     
 0.014 0.9 0.347 0.568     
NJ   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant -1.2e-05 0.00053   0.982 0.00036 0.00057   0.528 
Age 0.00029 3.4e-05 0.78 2.2e-11 0.00028 3.4e-05 0.76 4.72e-11 
Sex 1.8e-05 0.00023 0.0071 0.938 8.7e-05 0.00023 0.034 0.711 
Ind. ASD     -2.7e-05 1.6e-05 -0.15 0.107 
R2 0.61    0.63    
 
R2 
Change F p adj. p     
 0.02 2.7 0.107 0.226     
PS   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 320 50   6.59e-08 300 55   1.11e-06 
Age 0.46 3.2 0.021 0.887 0.7 3.3 0.032 0.832 
Sex 4.8 22 0.032 0.827 2.8 23 0.018 0.903 
Ind. ASD     0.82 1.6 0.076 0.61 
R2 0.0011    0.0065    
 
R2 
Change F p adj. p     
 0.0053 0.26 0.610 0.757     
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TPS   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 1 0.14   7.39e-09 1 0.16   3.18e-08 
Age 0.046 0.0093 0.59 7.72e-06 0.046 0.0094 0.58 1.41e-05 
Sex 0.1 0.064 0.19 0.113 0.11 0.065 0.2 0.0988 
Ind. ASD     -0.0027 0.0046 -0.071 0.555 
R2 0.33    0.34    
 
R2 
Change F p adj. p     
 0.0048 0.35 0.555 0.740     
RT   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 1.4 0.2   7.1e-09 1.5 0.22   1.95e-08 
Age 0.095 0.013 0.73 2.88e-09 0.093 0.013 0.72 6.8e-09 
Sex 0.21 0.09 0.23 0.0252 0.22 0.092 0.25 0.0195 
Ind. ASD     -0.0055 0.0065 -0.087 0.399 
R2 0.51    0.52    
 
R2 
Change F p adj. p     
 0.0071 0.72 0.399 0.624     
PA   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.31 0.11   0.00574 0.33 0.12   0.0077 
Age 0.034 0.0069 0.57 1.02e-05 0.033 0.007 0.57 1.74e-05 
Sex -0.033 0.047 -0.08 0.495 -0.029 0.049 -0.072 0.55 
Ind. ASD     -0.0013 0.0034 -0.046 0.698 
R2 0.36    0.36    
 
R2 
Change F p adj. p     
 0.002 0.15 0.698 0.771     
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Mean TE   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.053 0.026   0.0446 0.061 0.027   0.025 
Age 0.007 0.0017 0.51 0.000124 0.0068 0.0017 0.49 0.000187 
Sex -0.005 0.012 -0.052 0.67 -0.0058 0.011 -0.061 0.618 
Anxiety 
Count     -0.0011 0.00089 -0.15 0.217 
R2 0.27    0.29    
 
R2 
Change F p adj. p     
 0.022 1.6 0.217 0.372     
IIV of TE   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.044 0.056   0.44 0.053 0.058   0.367 
Age 0.013 0.0036 0.44 0.00109 0.012 0.0037 0.43 0.00149 
Sex -0.0055 0.025 -0.028 0.827 -0.0064 0.025 -0.033 0.8 
Anxiety 
Count     -0.0013 0.002 -0.083 0.515 
R2 0.2    0.21    
 
R2 
Change F p adj. p     
 0.0068 0.43 0.515 0.713     
NJ   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.00027 0.00054   0.617 0.00045 0.00055   0.422 
Age 0.00028 3.5e-05 0.75 1.94e-10 0.00027 3.5e-05 0.73 3.3e-10 
Sex -8.7e-05 0.00024 -0.034 0.719 -1e-04 0.00024 -0.041 0.663 
Anxiety 
Count     -2.4e-05 1.9e-05 -0.12 0.194 
R2 0.57    0.58    
 
R2 
Change F p adj. p     
 0.014 1.7 0.194 0.866     
PS   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 310 48   3.51e-08 300 50   1.56e-07 
Age 0.62 3.1 0.028 0.845 0.84 3.2 0.038 0.792 
Sex 6.1 21 0.04 0.779 6.9 22 0.046 0.75 
Anxiety 
Count     1.2 1.7 0.1 0.485 
R2 0.0019    0.012    
 
R2 
Change F p adj. p     
 0.0098 0.5 0.485 0.698     
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TPS   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 1 0.14   1.43e-09 1.1 0.15   3.71e-09 
Age 0.044 0.0092 0.57 1.45e-05 0.044 0.0094 0.57 2.03e-05 
Sex 0.087 0.063 0.16 0.175 0.086 0.064 0.16 0.183 
Anxiety 
Count     -0.001 0.005 -0.025 0.834 
R2 0.31    0.31    
 
R2 
Change F p adj. p     
 0.00061 0.044 0.834 0.367     
RT   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 1.5 0.21   1.45e-09 1.6 0.21   1.03e-09 
Age 0.09 0.013 0.7 1.56e-08 0.088 0.013 0.69 2.62e-08 
Sex 0.17 0.092 0.2 0.0665 0.17 0.092 0.19 0.076 
Anxiety 
Count     -0.0089 0.0071 -0.13 0.216 
R2 0.47    0.49    
 
R2 
Change F p adj. p     
 0.016 1.6 0.216 0.372     
PA   Model 1       Model 2     
 B SE Std.B p B SE Std.B p 
Constant 0.35 0.11   0.0018 0.4 0.11   0.000447 
Age 0.032 0.0069 0.54 2.97e-05 0.03 0.0068 0.52 4.14e-05 
Sex -0.048 0.047 -0.12 0.315 -0.053 0.046 -0.13 0.255 
Anxiety 
Count     -0.0071 0.0036 -0.22 0.0553 
R2 0.33    0.38    
 
R2 
Change F p adj. p     
 0.048 3.9 0.055 0.142     
TE: Tracking Error, IIV of TE: Intra-Individual Variability of Tracking Error, NJ: Normalised 
Jerk, TPS: Time to Peak Speed, RT: Reaction Time, PA: Path Accuracy 
 
 
